The limits of endovascular aortic aneurysm repair  by Zarins, Christopher K.
1164
COMMENTS
Open surgical repair is highly successful in pre-
venting aneurysm rupture but is associated with a sig-
nificant morbidity and mortality rate. Endovascular
aneurysm repair can greatly reduce perioperative mor-
bidity and quickly return patients to normal function.
However, the efficacy of endovascular aneurysm
repair in altering the natural history of aneurysms and
in preventing death from aneurysm rupture is not yet
known. The case reported in this issue of the Journal
of Vascular Surgery1 highlights a number of impor-
tant issues and provides some important lessons relat-
ed to endovascular aneurysm repair.
COMMENTS REGARDING THE CASE
REPORT
The patient had an asymptomatic 7-cm aortic
aneurysm and was considered to be at high risk for
aneurysm rupture on the basis of the size of the
aneurysm. He was a suitable candidate for endovas-
cular aneurysm repair, and this was successfully
accomplished with a bifurcated endovascular graft.
The aneurysm was completely excluded from the
circulation, and there was no evidence of perigraft
flow in the aneurysm sac at 2 days, 1 month, 3
months, and 6 months after the procedure. This ini-
tial excellent result, however, was not maintained
because after 9 months an endoleak was discovered
for the first time on helical computed tomographic
angiography and color duplex ultrasound scan.
There was no change in aneurysm size, and the
patient was asymptomatic. Given this situation, the
authors prudently decided to perform an angiogram
to evaluate the new endoleak. Unfortunately, they
focused their efforts on investigating the lumbar
arteries by selective angiography of the internal iliac
arteries in hopes of coil embolization rather than
specifically evaluating the stent graft itself and its
attachment sites to the aorta and iliac arteries.
Three months later, 1 year after endovascular
repair, the endoleak was considerably larger and the
aneurysm had enlarged to 8 cm. Angiographic results
at this time revealed a 9-mm tear in the polyester graft
caused by erosion of the graft fabric by a moving,
angulated stent strut. In retrospect, graft erosion sure-
ly was present, albeit smaller, 3 months earlier when
the new onset endoleak was discovered. The fact that
the aneurysm had enlarged 1 cm in a 3-month period
and now measured 8 cm in diameter placed the patient
at a particularly high risk for rupture. At this point,
open surgical repair of the aneurysm was indicated, in
my view, particularly because there was evidence of dis-
ruption of the integrity of the stent graft, the patient
had no prohibitive medical risk, and the aneurysm was
large and enlarging.
Nonetheless, it was decided to persist with
endovascular strategies, thus testing the limits of this
approach. A second endovascular stent graft (tube
graft) of the same design was inserted within the
body of the previously placed bifurcated stent graft.
This reduced the size of the endoleak but did not
eliminate it. Further efforts at coil embolization of
lumbar arteries 1 month later similarly were not suc-
cessful in sealing the endoleak. Systemic pressure and
blood flow continued in the aneurysm sac, which
continued to enlarge and did eventually rupture.
That endovascular efforts to secondarily treat the
new onset endoleak failed is not surprising. The
Vanguard (Boston Scientific, Natick, Mass) bifurcated
endovascular aortic graft used in this patient consists
of a self-expanding nitinol stent framework within a
synthetic polyester graft. The individual nitinol stent
bodies are joined together end to end with numerous
separate polypropylene sutures, but the stent frame-
work is not attached to the polyester graft except at
the ends of the stent graft. If the sutures break, the
stent bodies can move in relation to one another with-
in the polyester graft. The stents are on the inside of
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the graft, so it is highly unlikely that placement of a
new endograft within the disrupted device could be
effective because freely moving stent bodies would
occupy the space between the new polyester graft and
the perforation in the original polyester graft, thus
preventing a seal. Indeed, in this patient, the new
stent graft served to reduce the size of the endoleak
but was not effective in sealing it.
Persistence in applying secondary and tertiary
endovascular treatments after an unsuccessful
endovascular aneurysm repair often is the result of a
common misperception regarding the end point of
endovascular aneurysm repair. The misconception
here is that the objective or end point of endovascu-
lar repair is to prevent or correct endoleak. Rather,
the primary objective is to prevent enlargement and
rupture of the aneurysm. The presence or absence of
an endoleak is a poor predictor of subsequent events,
as is well demonstrated by this case. Efforts at coil
embolization in this patient may have diverted atten-
tion from the clear fact that the aneurysm was large
and enlarging and that there was a hole in the poly-
ester graft. Reduction in the demonstrated size of the
endoleak may have lead to a false sense of security,
which allowed the aneurysm to continue to enlarge
and ultimately rupture.
The natural history of aneurysm repair is to
enlarge and rupture with the risk for rupture increas-
ing greatly with increasing size. It is remarkable that
this patient did not rupture his aneurysm for 11
months after it was discovered that a new endoleak
had developed. During that period of time, the
aneurysm increased from 7 to 10 cm. There was
ample time to electively repair the aneurysm before
rupture. Furthermore, when the aneurysm rup-
tured, the leak was small and the patient’s condition
was hemodynamically stable, which allowed success-
ful surgical repair. This may be caused by the fact
that the stent graft being in place in the aorta may
have prevented a large exsanguinating hole in the
aorta, allowing flow only through a small endoleak
or inadequate seal. Thus, although the endograft did
not ultimately prevent aneurysm rupture, perhaps,
at least in this case, it served to prevent death from
rupture and allowed time for surgical repair.
GENERAL COMMENTS
Endovascular stent grafts are new devices of var-
ious designs, and all potential failure modes are not
yet known. Suture breakage in the Vanguard graft
has been noted in the past, and graft erosion, such as
was seen in this case, has been reported in six
patients with the Vanguard stent graft.1
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This problem may be specific to this particular
device and may not apply to other stent grafts with
different structures and designs. A not dissimilar
technical problem occurred in the clinical investiga-
tion of the Endovascular Technologies endograft
when fractures of metallic struts were discovered.2
This problem was corrected by the manufacturer,
and no further strut fractures have been reported.
One might anticipate that modification of device
design of the Vanguard graft will eliminate the
potential for suture breakage that could lead to graft
erosion. The technical difficulties of some endograft
device designs do not negate the overall value of
endovascular aneurysm repair. The clinical benefit of
a significant reduction in the morbidity rate associat-
ed with aneurysm repair will stimulate refinement of
manufactured devices and eliminate or minimize
technical failures. This case, however, serves as a
warning that patients who undergo endovascular
aneurysm repair should be followed closely and
should undergo treatment according to normal sur-
gical standards, with evaluation of risk of rupture
compared with the risk of operation. Device manu-
facturers must evaluate and reevaluate structure and
design of their products to ensure device integrity.
The availability of endovascular stent grafts will
enhance our ability to treat patients with aortic
aneurysms with improved safety and broader applic-
ability to elderly patients with significant medical
comorbidities. However, endovascular stent grafts
should not be viewed as the only treatment strategy
and should not cloud good surgical judgement.
Although “conversion” to open surgical repair is
reported as a primary indicator of failure of endovas-
cular aneurysm repair, it should be remembered that
the primary end point in the treatment of aneurysms
is to prevent rupture. Misguided efforts aimed at
avoiding surgical conversion, deferring needed open
repair, or reserving surgical repair to only those
patients with aneurysm rupture will have an adverse
impact on patient care.
A number of lessons can be learned from this
experience and other experiences. First, the absence of
an endoleak after successful endovascular aneurysm
repair does not guarantee continued long-term suc-
cess. All patients who have undergone endovascular
repair should undergo continued close follow-up and
aortic imaging. Second, the development of a new
endoleak, months after successful repair, should be
suspected to have a significant problem that needs
further investigation. The structure and design of the
endograft should be well understood, and secondary
treatments should be made on the basis of correcting
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the problem, not eliminating radiographic evidence of
endoleak. Finally, the limits of endovascular aneurysm
repair must be guided by good judgement, not by the
technical capabilities of administering catheter-based
treatments. This judgment must be made on the basis
of an understanding of the natural history and risk of
rupture of aneurysms, surgical experience, and clinical
wisdom. The endovascular device failure in this case is
an issue for the manufacturer. The patient treatment
failure and aneurysm rupture is an issue for the treat-
ing physicians.
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